Beckman Coulter's Stock Rises on Strong Q1 Revenue, Profit Growth | GenomeWeb
This article has been updated to include comments from a conference call and a stock quote.
 
NEW YORK (GenomeWeb News) – Shares of Beckman Coulter rose more than 7 percent in Wednesday trade after the firm reported that its first quarter revenues rose 19.1 percent, or 14.5 percent on a constant currency basis, and its profits jumped 15.6 percent year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.